Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis

Sponsor
Thompson Cancer Survival Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05369234
Collaborator
(none)
100
1
4
24.3
4.1

Study Details

Study Description

Brief Summary

As mentioned above, several prior studies have shown the positive effects of oral use of aloe vera juice in managing chemotherapy and radiation-induced oral mucositis and esophagitis. This study aims to add to the existing body of research around aloe vera juice and its effects on oral mucositis and esophagitis. The intention is to determine whether aloe vera juice should be considered as part of standard treatment.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: 100% Aloe Vera Juice
  • Combination Product: Magic Mouthwash
  • Combination Product: Salt and Baking soda rinse
  • Drug: Carafate
Phase 3

Detailed Description

Oral mucositis and esophagitis are side effects of both chemotherapy and radiation that can interfere with a patient's ability to eat, drink, and maintain weight. They can significantly impact quality of life as well as creating the need for treatment breaks. Treatment breaks decrease the efficacy of treatment. A suspected method of treatment is aloe vera juice. Several prior studies have shown the positive effects of oral use of aloe vera juice in managing chemotherapy and radiation-induced oral mucositis and esophagitis. Aloe vera, or aloe barbadensis miller as it is known in the botanical world, is a succulent plant used in traditional medicine.

In this study, the aloe vera juice that will be utilized by the patients is George's 100% Aloe Vera Juice, manufactured by Warren Laboratories. This aloe vera juice has been fractionally distilled to remove anthraquinone and other compounds that can cause nausea, abdominal cramping, and diarrhea, as well as bitter, unpleasant taste.

This study aims to add to the existing body of research around aloe vera juice and its effects on oral mucositis and esophagitis. The intention is to determine whether aloe vera juice, in combination with standard treatments, is more effective in management of oral mucositis and esophagitis than standard treatment alone. If so, aloe vera offers a natural, cost-effective option for managing radiation and chemotherapy side effects.

Patients in arm 1 of cohort 1 or 2 will be given 3 gallons of George's 100% Aloe Vera Liquid Supplement, free of cost, to utilize throughout treatment. Patients in cohort 1, arm 2 will be asked to swish and spit ¼ cup (2 ounces) of the aloe vera juice 3 times per day, 7 days per week while they are on radiation treatment. Patients in cohort 2, arm 2 will be asked to drink ¼ cup (2 ounces) of aloe vera juice 3 times per day, 7 days per week while they are on chemotherapy and radiation treatment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Cohort 1-Lip,oral cavity, hard palate, tongue, tonsil, pharyngeal, laryngeal, neck cancers receiving chemotherapy and radiation therapy will be randomized to receiving either aloe vera juice + standard of care treatments or standard of care treatments. Cohort 2--Esophageal, mediastinal, chest wall cancers receiving chemotherapy and radiation will be randomized to receiving aloe vera juice + standard of care treatments or standard of care treatments.Cohort 1-Lip,oral cavity, hard palate, tongue, tonsil, pharyngeal, laryngeal, neck cancers receiving chemotherapy and radiation therapy will be randomized to receiving either aloe vera juice + standard of care treatments or standard of care treatments. Cohort 2--Esophageal, mediastinal, chest wall cancers receiving chemotherapy and radiation will be randomized to receiving aloe vera juice + standard of care treatments or standard of care treatments.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis: a Single-blind Randomized Controlled Trial
Actual Study Start Date :
Jan 20, 2022
Anticipated Primary Completion Date :
Jan 30, 2024
Anticipated Study Completion Date :
Jan 30, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cohort 1--Arm 1

Aloe Vera Juice + Standard of Care Treatments Swish and spit ¼ cup (2 ounces) of 100% aloe vera juice 3 times per day, 7 days per week as first line treatment, standard of care agents added as needed

Dietary Supplement: 100% Aloe Vera Juice
George's 100% Aloe Vera Liquid Supplement

Combination Product: Magic Mouthwash
Magic Mouthwash

Combination Product: Salt and Baking soda rinse
Mouth rinse made with salt and baking soda

Drug: Carafate
Carafate taken as a slurry

Active Comparator: Cohort 1--Arm 2

Standard of Care Treatments Use salt and baking soda rinses, Magic Mouthwash, Carafate, etc.

Combination Product: Magic Mouthwash
Magic Mouthwash

Combination Product: Salt and Baking soda rinse
Mouth rinse made with salt and baking soda

Drug: Carafate
Carafate taken as a slurry

Experimental: Cohort 2--Arm 1

Aloe Vera Juice + Standard of Care Treatments Drink ¼ cup (2 ounces) of 100% aloe vera juice 3 times per day, 7 days per week as first line treatment, standard of care agents added as needed

Dietary Supplement: 100% Aloe Vera Juice
George's 100% Aloe Vera Liquid Supplement

Combination Product: Magic Mouthwash
Magic Mouthwash

Combination Product: Salt and Baking soda rinse
Mouth rinse made with salt and baking soda

Drug: Carafate
Carafate taken as a slurry

Active Comparator: Cohort 2-- Arm 2

Standard of Care Treatments Use salt and baking soda rinses, Magic Mouthwash, Carafate, etc.

Combination Product: Magic Mouthwash
Magic Mouthwash

Combination Product: Salt and Baking soda rinse
Mouth rinse made with salt and baking soda

Drug: Carafate
Carafate taken as a slurry

Outcome Measures

Primary Outcome Measures

  1. Prevention of Oral Mucositis and Esophagitis [10 weeks]

    to determine whether to add oral aloe vera juice to standard of care treatments for lip, oral cavity, hard palate, tongue, tonsil , pharyngeal, laryngeal, neck , esophageal, mediastinal, and chest wall cancers will help prevent oral mucositis and esophagitis symptoms while patients undergo radiation therapy. Symptoms will be assessed using the CTCAE v. 5.0 weekly while on treatment to determine if the addition of aloe vera juice impacts these symptoms when compared to subjects that don't receive aloe vera juice.

  2. Management of Oral Mucositis and Esophagitis [10 weeks]

    to determine whether to add oral aloe vera juice to standard of care treatments for lip, oral cavity, hard palate, tongue, tonsil , pharyngeal, laryngeal, neck , esophageal, mediastinal, and chest wall cancers will help manage oral mucositis and esophagitis symptoms while patients undergo radiation therapy. Symptoms will be assessed using the CTCAE v. 5.0 weekly while on treatment to determine if the addition of aloe vera juice impacts these symptoms when compared to subjects that don't receive aloe vera juice.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • must have signed and dated an IRB approved consent form that conforms to federal and institutional guidelines

  • Age >/= 18 years

  • Confirmed lip, oral cavity, hard palate, tongue, tonsil, pharyngeal, neck, esophageal, mediastinal, and/or chest wall cancers

  • Women of child-bearing potential and men must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study participation.

  • Men treated or enrolled on this protocol must agree to use adequate contraception prior to the study, for the duration of study participation.

Exclusion Criteria:
  • Patients who are not on concurrent chemotherapy and radiation.

  • History of allergic reactions attributed to compounds of similar chemical or biologic composition to aloe vera juice.

  • Patients with psychiatric illness/social situations that would limit compliance with study requirements.

  • Pregnant women or women who are breastfeeding

Contacts and Locations

Locations

Site City State Country Postal Code
1 Thompson Cancer Survival Center Radiation Oncology Services Knoxville Tennessee United States 37916

Sponsors and Collaborators

  • Thompson Cancer Survival Center

Investigators

  • Principal Investigator: Daniel Scaperoth, MD, Thompson Cancer Survival Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Thompson Cancer Survival Center
ClinicalTrials.gov Identifier:
NCT05369234
Other Study ID Numbers:
  • 2022-404 INV Aloe_Oncology
First Posted:
May 11, 2022
Last Update Posted:
May 11, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
Yes
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 11, 2022